ARCHIVES

ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards?

This article is from The Cancer Letter archive.

Vol. 28 No. 41 | November 8, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Friends of Cancer Research Honor Specter; Dole Tapes Announcement For CaP CURE

January 24, 1997

NCCS Networker Volume 7 Issue 4, Assembly Edition 1993

September 13, 1993

Also FDA clarifies data requirements for phase I IND applications.

April 29, 2005

Cancer Groups In Campaign To Draft Pazdur For FDA.

March 2, 2001

In Brief: Moertel To Deliver Karnofsky Lecture; Hopkins, Cold Spring Harbor Receive Bristol-Myers Awards

April 25, 1986

Cancers Linked To Agent Orange In IOM Review

August 13, 1993